Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Padma Kadiyala

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3273-9905; OpenAlex author ID A5069563793. Sources: OpenAlex.

Their work

Papers
9 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 4 papers

Papers 9

  1. Longitudinal Analysis of Matched Patient Biospecimens Reveals Neural Reprogramming of Cancer-Associated Fibroblasts Following Chemotherapy in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-26-0823↗
  2. Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization. First author DOI 10.1158/2159-8290.cd-25-0377↗
  3. Asynchronous Evolution of Epithelium and Stroma Differentiates Precursor Lesions from Pancreatic Cancer. First author DOI 10.1158/2159-8290.cd-25-2001↗
  4. Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer. First author DOI 10.1158/2326-6066.cir-25-1300↗
  5. Primary and metastatic cellular landscapes in human pancreatic cancer. Co-author DOI 10.1016/j.isci.2025.113012↗
  6. KRT17high/CXCL8+ Tumor Cells Display Both Classical and Basal Features and Regulate Myeloid Infiltration in the Pancreatic Cancer Microenvironment. First author DOI 10.1158/1078-0432.ccr-23-1421↗
  7. WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer. Co-author DOI 10.1084/jem.20220503↗
  8. Arginase 1 is a key driver of immune suppression in pancreatic cancer. Co-author DOI 10.7554/elife.80721↗
  9. Using Single Cell Transcriptomics to Elucidate the Myeloid Compartment in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.881871↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eileen S. Carpenter · 9 shared papers, 2022–2026 · strength 1.73
  2. Marina Pasca di Magliano · 8 shared papers, 2023–2026 · strength 1.47
  3. Ahmed M. Elhossiny · 7 shared papers, 2022–2026 · strength 1.42
  4. Filip Bednar · 7 shared papers, 2023–2026 · strength 1.30
  5. Timothy L. Frankel · 6 shared papers, 2024–2026 · strength 1.16
  6. Katelyn L. Donahue · 6 shared papers, 2023–2026 · strength 1.05
  7. Yaqing Zhang · 4 shared papers, 2023–2026 · strength 0.79
  8. Costas Andreas Lyssiotis · 4 shared papers, 2023–2026 · strength 0.75
  9. Jiaqi Shi · 4 shared papers, 2024–2026 · strength 0.74
  10. Vaibhav Sahai · 3 shared papers, 2024–2026 · strength 0.53
  11. Rosa Elena Menjivar · 3 shared papers, 2023–2026 · strength 0.50
  12. Zeribe C. Nwosu · 3 shared papers, 2023–2026 · strength 0.47
  13. Wenting Du · 3 shared papers, 2023–2024 · strength 0.44
  14. Brian D. Griffith · 2 shared papers, 2026 · strength 0.43
  15. Emily L. Lasse Opsahl · 2 shared papers, 2025–2026 · strength 0.39
  16. Jorge D. Machicado · 2 shared papers, 2024–2026 · strength 0.34
  17. Howard C. Crawford · 2 shared papers, 2023–2025 · strength 0.33
  18. Samantha B. Kemp · 2 shared papers, 2024–2025 · strength 0.32
  19. Nina G. Steele · 2 shared papers, 2024–2025 · strength 0.32
  20. Valerie Gunchick · 2 shared papers, 2024–2025 · strength 0.32
  21. Holly Attebury · 1 shared paper, 2026 · strength 0.22
  22. Aylin Z. Henstridge · 1 shared paper, 2026 · strength 0.21
  23. Mark Joseph Truty · 1 shared paper, 2026 · strength 0.21
  24. Martín E. Fernández-Zapico · 1 shared paper, 2026 · strength 0.21
  25. Elana Judith Fertig · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.